Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Intel Forges Foundry Chip Collaboration With This TSMC Partner After Qualcomm, Amazon

Intel Corp (NASDAQ:INTC) and Media Tek Inc (OTC: MDTKF) collaborated to manufacture chips using Intel Foundry Services’ (IFS) advanced process technologies.  Intel said the…
byAnusuya Lahiri
July 25, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0
  • Intel Corp (NASDAQ:INTC) and Media Tek Inc (OTC: MDTKF) collaborated to manufacture chips using Intel Foundry Services’ (IFS) advanced process technologies. 
  • Intel said the first products would be manufactured in the next 18- to 24- month period and will be in a more mature technology process called Intel 16, with the chips used for smart devices, Reuters reports.
  • In addition to maintaining a close partnership with Taiwan Semiconductor Manufacturing Co Ltd (NYSE:TSM) in advanced process nodes, this collaboration will enhance MediaTek’s supply for mature process nodes.
  • The alliance aimed to help MediaTek build a more balanced, resilient supply chain by adding a new foundry partner with significant capacity in the U.S. and Europe.
  • MediaTek looks to use Intel process technologies to manufacture multiple chips for various smart edge devices. 
  • IFS offers a broad manufacturing platform with technologies optimized for high performance, low power, and always-on connectivity.
  • Intel previously disclosed foundry business collaborations with Qualcomm Inc (NASDAQ:QCOM) and Amazon.com Inc (NASDAQ:AMZN).
  • Qualcomm used Intel’s new transistor technology to reduce chips’ power consumption. Amazon used Intel’s packaging technology.
  • Price Action: INTC shares traded lower by 0.94% at $38.83 on the last check Monday.
 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Aurora Touts 41% YoY Increase In International Medical Cannabis Q3 Revenue, Expands In Australia Via New Acquisition

By Jelena Martinovic
February 8, 12:04 PM
Canadian medical cannabis company Aurora Cannabis reported its financial and operational results for Q3 2024. Net revenue increased to CAD64.4m ($42m), up from CAD61.1m in the same quarter the previous year. Medical cannabis net revenue rose by 16% to CAD45.1m, representing 70% of Aurora's consolidated net revenue. Gross profit reached CAD19.8m, up from CAD3.7m in Q3 2022, with adjusted gross profit before fair value adjustments increasing to CAD32.4m from CAD28m. The company recorded a CAD25.5m net loss compared to CAD67.2m in the same quarter in the previous year. Adjusted EBITDA came in at CAD4.3m, up from CAD3m. Miguel Martin, CEO of Aurora, said the company's international medical net revenue had seen year-on-year growth of 41%.

ACB